Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

BCTX BriaCell Therapeutics

Watchlist
5.770
+0.130+2.30%
Close  12/08 16:00 ET
5.840
+0.070+1.21%
Post Mkt Price 12/08 16:52 ET
High
5.944
Open
5.710
Turnover
2.39M
Low
5.400
Pre Close
5.640
Volume
419.40K
Market Cap
89.54M
P/E(TTM)
Loss
52wk High
12.090
Shares
15.52M
P/E(Static)
Loss
52wk Low
4.060
Float Cap
66.91M
Bid/Ask %
-33.33%
Historical High
12.470
Shs Float
11.60M
Volume Ratio
2.47
Historical Low
2.815
Dividend TTM
--
Div Yield TTM
--
P/B
8.66
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
3.62%
Amplitude
9.65%
Avg Price
5.699
Lot Size
1
Float Cap
66.91M
Bid/Ask %
-33.33%
Historical High
12.470
Shs Float
11.60M
Volume Ratio
2.47
Historical Low
2.815
Dividend TTM
--
P/B
8.66
Dividend LFY
--
Turnover Ratio
3.62%
Amplitude
9.65%
Avg Price
5.699
Lot Size
1
Price Forecast

News

Comment

No Data

Company Overview More
BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company, which engages in the development of immunotherapies for treatment of cancer. Its technologies include Bria-IMT and Bria-OTS. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
CEO: Dr. William Williams, M.D.
Market: NASDAQ
Listing Date: 02/24/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist